Men with prostate cancer who get hormone therapy experience hot flashes, where they experience intense and sudden heat and ...

Akeega, an oral dual mechanism therapy pairing niraparib with abiraterone, has won a positive committee opinion in Europe for ...

Metastasis-directed therapy (MDT) significantly improved outcomes in patients with oligometastatic prostate cancer, according ...

Join Tom and Mike as they share an important update on Tom's prostate cancer journey. In this video, they discuss Tom's ...

A national clinical trial led by the Alliance for Clinical Trials in Oncology has found that oxybutynin, a drug often used to ...

Radiation therapy (also called radiotherapy) uses high-energy beams or subatomic particles to damage the DNA inside prostate cancer cells. After enough damage, the cells cannot multiply, and they die.

Thousands of men with incurable prostate cancer will be offered a lifeline after an about-turn on NHS treatment.

Metastasis-directed therapy (MDT) delivered via stereotactic body radiotherapy has gained substantial attention over the past decade. Landmark trials such as STOMP1 and ORIOLE2 fundamentally shifted ...

Because treatment of the whole prostate can lead to long-term side effects in patients with prostate cancer, interest in ...

A real-world study found Erleada reduced the risk of death compared with Nubeqa in patients with metastatic ...

As we gear up to observe World Cancer Day 2026 under the theme 'United by Unique', let's take a look at the stages of ...

Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, ...